Fred Alger Management LLC Has $147.44 Million Position in Danaher Co. (NYSE:DHR)

Fred Alger Management LLC lifted its stake in shares of Danaher Co. (NYSE:DHR) by 32.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 530,320 shares of the conglomerate’s stock after buying an additional 130,435 shares during the quarter. Danaher comprises about 0.7% of Fred Alger Management LLC’s portfolio, making the stock its 29th largest holding. Fred Alger Management LLC owned approximately 0.07% of Danaher worth $147,440,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of DHR. FMR LLC increased its position in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the period. Legal & General Group Plc grew its stake in shares of Danaher by 2.4% in the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate’s stock valued at $1,490,112,000 after acquiring an additional 139,989 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Danaher by 3.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock worth $1,417,342,000 after acquiring an additional 148,251 shares during the period. Fisher Asset Management LLC raised its stake in Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock worth $1,265,725,000 after purchasing an additional 116,299 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. UBS Group dropped their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Raymond James dropped their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Trading Up 1.0 %

Shares of DHR stock opened at $238.83 on Friday. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70. The stock’s fifty day simple moving average is $255.25 and its 200 day simple moving average is $259.52. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $172.50 billion, a P/E ratio of 45.58, a P/E/G ratio of 4.39 and a beta of 0.85.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the firm posted $2.02 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.